USE OF PARP INHIBITOR IN TREATING CHEMOTHERAPY-RESISTANT OVARIAN CANCER OR BREAST CANCER

• 收藏
• 分享

专利权人:

JIANGSU HENGRUI MEDICINE CO.; LTD.

发明人:

Quanren WANG

申请号：

US16767385

公开号：

US20200281923A1

申请日:

2018.12.05

申请国别(地区):

US

年份:

2020

代理人:

摘要：

A use of a PARP inhibitor in treating a chemotherapy-resistant ovarian cancer or breast cancer is described. The PARP inhibitor can be a compound as shown in general formula (B) and a pharmaceutically acceptable salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/